Arcadia Biosciences (RKDA) Profit After Tax (2014 - 2025)

Arcadia Biosciences has reported Profit After Tax for 12 years, with the latest figure at -$1.3 million in Q4 2025.

• For the quarter ending Q4 2025, Profit After Tax rose 67.13% year-over-year to -$1.3 million; the trailing twelve-month figure through Dec 2025 stood at -$2.3 million (up 64.6% YoY), and the FY2025 full-year result was -$2.3 million, up 66.77% from the prior year.
• Profit After Tax for Q4 2025 stood at -$1.3 million, down from $856000.0 in the prior quarter.
• The five-year high for Profit After Tax was $144.0 million in Q2 2021, with the low at -$9.4 million in Q1 2023.
• Historically, Profit After Tax has averaged $4.9 million across 5 years, with a median of -$2.6 million in 2021.
• Annual changes were most pronounced in 2021 — Profit After Tax jumped 1555.57% — and 2025, when it tumbled 520.17%.
• Arcadia Biosciences' Profit After Tax stood at -$7.5 million in 2021, then jumped by 40.43% to -$4.5 million in 2022, then soared by 35.83% to -$2.9 million in 2023, then sank by 41.75% to -$4.1 million in 2024, then surged by 67.13% to -$1.3 million in 2025.
• The last three Profit After Tax figures came in at -$1.3 million (Q4 2025), $856000.0 (Q3 2025), and -$4.5 million (Q2 2025), per Business Quant data.